|1.||Marsden, Joanne T: 4 articles (01/2014 - 12/2003)|
|2.||Harper, Pauline: 4 articles (01/2014 - 04/2006)|
|3.||Bonkovsky, Herbert L: 3 articles (09/2015 - 07/2013)|
|4.||Puy, Hervé: 3 articles (09/2015 - 02/2014)|
|5.||Gouya, Laurent: 3 articles (09/2015 - 02/2014)|
|6.||Rees, David C: 3 articles (01/2014 - 08/2012)|
|7.||Benton, Christopher M: 3 articles (02/2013 - 02/2012)|
|8.||Lim, Chang Kee: 3 articles (02/2013 - 02/2012)|
|9.||Moniz, Caje: 3 articles (02/2013 - 02/2012)|
|10.||Sardh, Eliane: 3 articles (01/2012 - 04/2006)|
|1.||Acute Intermittent Porphyria (Porphyria, Acute)
12/01/2008 - "Improved identification of acute porphyria requires heightened clinical awareness and access to urinary porphobilinogen measurement. "
07/01/2000 - "The goal of this study was evaluate 300 psychiatric patients and 150 control subjects to detect acute intermittent porphyria by measurement of porphobilinogen (PBG) deaminase activity in blood. "
05/01/1997 - "Molecular analysis of porphobilinogen (PBG) deaminase gene mutations in acute intermittent porphyria: first study in patients of Slavic origin."
09/01/2011 - "Demonstration of substantially increased urinary excretion of porphobilinogen is the cornerstone of diagnosing acute porphyria crisis. "
08/15/2011 - "Accurate determinations of 5-aminolevulinic acid (ALA) and porphobilinogen (PBG) in physiologic fluids are required for the diagnosis and therapeutic monitoring of acute porphyrias. "
09/01/2011 - "The aim of this study was to critically describe and to evaluate a semi-quantitative rapid test for urinary porphobilinogen determination which is commercially available and recommended by the American Porphyria Foundation. "
09/01/2015 - "Once suspected, the diagnosis of porphyria can be rapidly established by checking random urinary porphobilinogen. "
09/01/2001 - "Measurement of porphobilinogen (PBG) is useful in the diagnosis of the acute neurologic porphyrias. "
03/01/1996 - "Porphyria has been associated with an increase in plasma levels of 5-aminolevulinic acid and porphobilinogen. "
03/01/1992 - "Postoperatively urinary porphobilinogen excretion (625 mumol.day-1) exceeded the upper limit of normal but no symptoms of porphyria developed. "
|3.||Hereditary Coproporphyria (Coproporphyrinogen Oxidase Deficiency)
10/01/1996 - "Simple screening tests, urinary porphobilinogen (PBG) for acute intermittent porphyria (AIP) and fecal coproporphyrin for hereditary coproporphyria (HCP), were performed in a family study of AIP and HCP. "
01/01/2006 - "Summary A Caucasian male had symptoms of acute porphyria, with increases in urinary delta-aminolaevulinic acid (ALA), porphobilinogen (PBG) and coproporphyrin that were consistent with hereditary coproporphyria (HCP). "
08/01/2000 - "Especially, we measured the coproporphyrin isomers I and III. The group of hereditary coproporphyria patients exhibited a significantly higher (p<0.0001) excretion of urinary porphyrin precursors, delta-aminolevulinic acid (median = 84 micromol/24 h) and porphobilinogen (median = 39 micromol/24 h), as compared to controls (delta-aminolevulinic acid: 22 micromol/24 h, porphobilinogen: 3 micromol/24 h; median, n = 20). "
02/01/2008 - "Large increases of urinary porphobilinogen (PBG) indicate acute porphyria, which may be due to acute intermittent porphyria, variegate porphyria, or hereditary coproporphyria. "
12/01/1979 - "As a consequence of this secondary control, there is excessive excretion of the porphyrin precursors delta-aminolaevulinic acid and porphobilinogen in the acute porphyrias and excessive excretion of porphyrins leading to solar photosensitivity in the non-acute porphyrias and in variegate and hereditary coproporphyria. "
02/01/1972 - "In iron-deficiency anaemia the excretion of both porphobilinogen and delta-aminolevulinic acid was increased, whereas in patients with rheumatoid arthritis only the porphobilinogen excretion was increased.A further study on the erythrocyte activity of delta-aminolevulinic acid dehydrase showed a higher activity in the erythrocytes from patients with rheumatoid arthritis compared with healthy controls."
|1.||Aminolevulinic Acid (Levulan)
|7.||Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)
|9.||levulinic acid (magnesium levulinate)
|1.||Renal Dialysis (Hemodialysis)